Article
Disruption of metabolic licensing by JAK inhibitors constrains CD8 T cell activation and effector function
2025-10-27
Abstract excerpt
<title>Abstract</title> <p>Janus kinase inhibitors (JAKis) are widely prescribed for autoimmune diseases, but their use is associated with increased infection risk. The mechanisms underlying this susceptibility remain unclear. CD8 T cells play a central role in antimicrobial defense, yet little is known about how JAKis reprogram their activation and effector programs. Here, we investigated naïve and memory CD8 T...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8dcaaca1-5a62-5661-8b09-5c54e2c5b09a
- DOI
- 10.21203/rs.3.rs-7794494/v1
